BG63276B1 - Метод за производство на модифициран инхибитор палидипин на колагениндуцирано тромбоцитно натрупване - Google Patents

Метод за производство на модифициран инхибитор палидипин на колагениндуцирано тромбоцитно натрупване Download PDF

Info

Publication number
BG63276B1
BG63276B1 BG101226A BG10122697A BG63276B1 BG 63276 B1 BG63276 B1 BG 63276B1 BG 101226 A BG101226 A BG 101226A BG 10122697 A BG10122697 A BG 10122697A BG 63276 B1 BG63276 B1 BG 63276B1
Authority
BG
Bulgaria
Prior art keywords
palidipine
asp
protein
seq
amino acid
Prior art date
Application number
BG101226A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG101226A (en
Inventor
Christiane Noeske-Jungblut
Andreas Becker
Bernard Haendler
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of BG101226A publication Critical patent/BG101226A/xx
Publication of BG63276B1 publication Critical patent/BG63276B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BG101226A 1994-09-12 1997-02-12 Метод за производство на модифициран инхибитор палидипин на колагениндуцирано тромбоцитно натрупване BG63276B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94250224 1994-09-12
PCT/EP1995/003573 WO1996008563A1 (en) 1994-09-12 1995-09-11 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin

Publications (2)

Publication Number Publication Date
BG101226A BG101226A (en) 1998-10-30
BG63276B1 true BG63276B1 (bg) 2001-08-31

Family

ID=8217517

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101226A BG63276B1 (bg) 1994-09-12 1997-02-12 Метод за производство на модифициран инхибитор палидипин на колагениндуцирано тромбоцитно натрупване

Country Status (22)

Country Link
US (1) US5882887A (ja)
EP (1) EP0781334A1 (ja)
JP (1) JPH10505502A (ja)
CN (1) CN1075836C (ja)
AU (1) AU701643B2 (ja)
BG (1) BG63276B1 (ja)
BR (1) BR9508910A (ja)
CA (1) CA2199719A1 (ja)
CZ (1) CZ76297A3 (ja)
FI (1) FI971013A0 (ja)
HU (1) HU222398B1 (ja)
IL (1) IL115272A0 (ja)
MX (1) MX9701720A (ja)
NO (1) NO971110L (ja)
NZ (1) NZ293261A (ja)
PL (1) PL184617B1 (ja)
RO (1) RO117971B1 (ja)
RU (1) RU2186110C2 (ja)
SI (1) SI9520093A (ja)
SK (1) SK29297A3 (ja)
WO (1) WO1996008563A1 (ja)
ZA (1) ZA957649B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774107B1 (en) * 1999-03-18 2004-08-10 Merck Patent Gmbh Protein for blocking platelet adhesion
CA2578072A1 (en) * 2004-12-28 2006-07-06 Ares Trading S.A. Compositions and methods for treating schizophrenia and related disorders
US7691839B2 (en) * 2005-09-28 2010-04-06 Biovascular, Inc. Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
US20110034396A1 (en) * 2005-09-28 2011-02-10 Biovascular, Inc. Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions
TWI391143B (zh) * 2005-11-04 2013-04-01 Otsuka Pharma Co Ltd 血小板凝集抑制劑組成物
WO2012172427A2 (en) * 2011-06-14 2012-12-20 National Taiwan University Peptide compounds for inhibition of platelet aggregation
FR2979346B1 (fr) 2011-08-23 2013-09-27 Univ Joseph Fourier Nanocorps anti-vcam-1
KR102063195B1 (ko) 2012-02-07 2020-01-07 글로벌 바이오 테라퓨틱스, 인크. 핵산 전달의 구획화된 방법 및 이의 조성물 및 용도
MX2015002994A (es) 2012-09-07 2016-01-14 Inserm Inst Nat De La Santé Et De La Rech Médicale Peptidos de inhibidores obtenidos del receptor desencadenante expresado en celulas mieloides de tipo 1 (trem-1) y transcrito similar a trem 1 (tlt-1) y usos de los mismos.
US11364032B2 (en) 2013-08-08 2022-06-21 Global Bio Therapeutics, Inc. Clamp device for minimally invasive procedures and uses thereof
FR3058143B1 (fr) 2016-10-27 2021-03-12 Univ Grenoble Alpes Nanocorps anti-tau
CN118139655A (zh) 2021-08-13 2024-06-04 特里奥万斯控股公司 皮肤替代组合物及其产生和使用方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0371041A1 (en) * 1987-06-24 1990-06-06 Novo Nordisk A/S A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation
US5756454A (en) * 1991-09-05 1998-05-26 Schering Aktiengesellschaft Collagen-induced platelet aggregation inhibitor
AU672584B2 (en) * 1991-09-05 1996-10-10 Schering Aktiengesellschaft Collagen-induced platelet aggregation inhibitor
US5705362A (en) * 1992-05-25 1998-01-06 Gist-Brocades, N.V. Modified signal sequences

Also Published As

Publication number Publication date
HU222398B1 (hu) 2003-06-28
AU701643B2 (en) 1999-02-04
HUT76972A (hu) 1998-01-28
CA2199719A1 (en) 1996-03-21
BR9508910A (pt) 1997-10-28
MX9701720A (es) 1997-06-28
PL319078A1 (en) 1997-07-21
US5882887A (en) 1999-03-16
CN1075836C (zh) 2001-12-05
AU3565795A (en) 1996-03-29
SI9520093A (en) 1997-08-31
PL184617B1 (pl) 2002-11-29
NO971110L (no) 1997-05-07
FI971013A (fi) 1997-03-11
JPH10505502A (ja) 1998-06-02
CZ76297A3 (cs) 1998-01-14
NO971110D0 (no) 1997-03-11
WO1996008563A1 (en) 1996-03-21
IL115272A0 (en) 1995-12-31
ZA957649B (en) 1996-04-15
FI971013A0 (fi) 1997-03-11
CN1159828A (zh) 1997-09-17
SK29297A3 (en) 1997-10-08
BG101226A (en) 1998-10-30
EP0781334A1 (en) 1997-07-02
RU2186110C2 (ru) 2002-07-27
RO117971B1 (ro) 2002-11-29
NZ293261A (en) 1998-11-25

Similar Documents

Publication Publication Date Title
JP4344136B2 (ja) アポリポタンパク質類似体
BG63276B1 (bg) Метод за производство на модифициран инхибитор палидипин на колагениндуцирано тромбоцитно натрупване
US5935815A (en) Process for micro biological production of proteins
CA2130900C (en) Therapeutic domains of von willebrand factor
EP0687731B1 (en) Secretion vector, transformed microorganisms containing said vector and manufacture of products from said microorganism
MXPA97001720A (en) Process for the manufacture of a modified palidipine, inhibitor of platelet aggregation induced by colag
JPH04503761A (ja) Ｐａｉ―２の変異体
KR100232683B1 (ko) 콜라겐에 의해 유도되는 혈소판 응집 억제제
EP0885956A1 (en) Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro) biological production of proteins
US8975370B2 (en) Inhibitor proteins of a protease and use thereof
RU2183214C2 (ru) Природный и рекомбинантный ингибиторы тромбина, их получение и применение
JP2798573B2 (ja) ヒト好中球エラスターゼ阻害活性を有する天然型ポリペプチドおよびそれを含有する医薬製剤
CN115572329B (zh) 一组活性增强代谢较慢的菲牛蛭基因重组水蛭素及其制备方法
EP0693925B1 (en) Production of a recombinant factor xa inhibitor of leech hirudo medicinalis
KR101034901B1 (ko) 아포리포단백질 유사체
JPH0353893A (ja) リンホトキシン誘導体の製造方法